ACADIA Pharmaceuticals
ACAD
#3920
Rank
C$3.43 B
Marketcap
$20.68
Share price
0.87%
Change (1 day)
-36.26%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): C$61.15 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$0.89 Billion. In 2023 the company made an earning of -C$70.18 Million, an increase over its 2022 earnings that were of -C$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$61.15 M-187.14%
2023 -C$70.18 Million-76.09%
2022 -C$0.3 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.39 Billion19.88%
2019 -C$0.33 Billion-3.92%
2018 -C$0.34 Billion-15.04%
2017 -C$0.4 Billion6.33%
2016 -C$0.38 Billion64.55%
2015 -C$0.23 Billion77.47%
2014 -C$0.13 Billion143.69%
2013 -C$52.19 Million81.93%
2012 -C$28.69 Million-8.73%
2011 -C$31.43 Million-251.39%
2010 C$20.75 M-133.2%
2009 -C$62.53 Million-30.82%
2008 -C$90.38 Million6.43%
2007 -C$84.92 Million25.89%
2006 -C$67.46 Million36.99%
2005 -C$49.24 Million37.22%
2004 -C$35.89 Million19.96%
2003 -C$29.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$44.65 Million-170.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$1.67 Billion-2,749.53%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.36 B 19,551.32%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.87 B 44,218.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$8.83 Billion-14,132.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$53.12 Million-184.45%๐Ÿ‡บ๐Ÿ‡ธ USA